Loading clinical trials...
Loading clinical trials...
Effects of Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes: A Multi-Centre, Randomised, Open-Label, Prospective Study
Conditions
Interventions
a2 UHT milk
Conventional UHT Milk
Locations
6
China
Foshan Maternity & Child Healthcare Hospital
Foshan, Guangdong, China
Panyu Maternal and Child Care Service Centre of Guangzhou
Guangzhou, Guangdong, China
Wuxi Maternal and Child Health Hospital
Wuxi, Jiangsu, China
Affiliated hospital of Jiangnan University
Wuxi, Jiangsu, China
Xuzhou Maternal and Child Health Hospital
Xuzhou, Jiangsu, China
First People's Hospital of Chengdu
Chengdu, Sichuan, China
Start Date
August 25, 2025
Primary Completion Date
September 1, 2026
Completion Date
September 1, 2026
Last Updated
February 6, 2026
Lead Sponsor
a2 Milk Company Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions